NDAORALCAPSULE, EXTENDED RELEASE
Approved
Apr 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
5/8 — Partial
INDERAL LA (propranolol hydrochloride) by ANI Pharmaceuticals is clinical pharmacology general propranolol is a nonselective, beta-adrenergic receptor-blocking agent possessing no other autonomic nervous system activity. First approved in 1983.
Drug data last refreshed 9h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Inderal LA is an extended-release oral formulation of propranolol hydrochloride, a nonselective beta-adrenergic receptor antagonist used to treat hypertension, angina pectoris, and cardiac arrhythmias. It works by blocking beta-adrenergic receptor sites, reducing heart rate, cardiac contractility, and blood pressure while decreasing myocardial oxygen demand. The extended-release formulation provides once-daily dosing with lower peak plasma levels than immediate-release propranolol but equivalent 24-hour clinical efficacy.
$8MPart D
LOE ApproachingDeclining
Product is in late-stage lifecycle with modest Part D claims; teams are likely focused on defensive strategies and line extension opportunities rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY General Propranolol is a nonselective, beta-adrenergic receptor-blocking agent possessing no other autonomic nervous system activity. It specifically competes with beta-adrenergic receptor-stimulating agents for available receptor sites. When access to beta-receptor sites is…
Worked on INDERAL LA at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.